primary sub-H2256 sam-Calretinin-H2256-A H2256 S MP Calretinin MAX VFN37 20X.tif (File)

Project:

OT2OD024899

Project (Entity type)

Id Namespace:

SPARC file namespace

Identifier Namespace (Entity type)

File Format:

image format

File Format (Entity type)

Dcc Asset:

C2M2 datapackage 202509.zip

Processed File (Entity type)

Dcc:

SPARC

DCC (Entity type)

Data Type:

Image

Data Type (Entity type)

Assay Type:

microscopy assay

Assay Type (Entity type)

Uncompressed Size In Bytes:8.39 MB

Size In Bytes:8.39 MB

Sha256:43fa41215204640ce50719d09c90889259699f79bfaef1acdf1d45d1fc8822ab

Persistent Id:sparc.drs:package/b2bb225b-5710-4979-b4f3-ed42ce122f39

Mime Type:image/tiff

Filename:primary__sub-H2256__sam-Calretinin-H2256-A__H2256_S_MP_Calretinin_MAX_VFN37_20X.tif

Creation Time:2022-07-06T06:33:22+00:00

Access Url:

https://services.scicrunch.io/sparc/drs/v1/package/b2bb225b-5710-4979-b4f3-ed42ce122f39

Results found

Linked to

	Label	Description
	N:dataset:cfc58362-1281-4998-8a1e-6ac0f7169772 Collection (Entity type)	List of antibodies that were tested in the human colon.
	N:dataset:cfc58362-1281-4998-8a1e-6ac0f7169772 H2256 Subject (Entity type)	A subject from SPARC produced as part of the OT2OD024899 project
	N:dataset:cfc58362-1281-4998-8a1e-6ac0f7169772 H2256 Calretinin-H2256-A Biosample (Entity type)	A biosample from SPARC produced as part of the OT2OD024899 project

N:dataset:cfc58362-1281-4998-8a1e-6ac0f7169772

Collection (Entity type)

List of antibodies that were tested in the human colon.

N:dataset:cfc58362-1281-4998-8a1e-6ac0f7169772 H2256

Subject (Entity type)

A subject from SPARC produced as part of the OT2OD024899 project

N:dataset:cfc58362-1281-4998-8a1e-6ac0f7169772 H2256 Calretinin-H2256-A

Biosample (Entity type)

A biosample from SPARC produced as part of the OT2OD024899 project

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.